Discovering PPP4R1L: A Potential Drug Target (G55370)

Target Name: PPP4R1L

NCBI ID: G55370

PPP4R1L

Other Name(s): PRO1085 | PPP4R1P1 | C20orf192 | Protein phosphatase 4 regulatory subunit 1 like (pseudogene) | protein phosphatase 4 regulatory subunit 1 like (pseudogene)

Discovering PPP4R1L: A Potential Drug Target

Proteins plays a vital role in almost every cellular process in the human body. They are the building blocks of life and are involved in almost every function that the body performs. One of the most important proteins is the protein known as PPP4R1L. This protein is a key regulator of the poly(ADP-ribose) polymerase (PARP) enzyme, which is involved in the production of reactive oxygen species (ROS) that can cause damage to cellular DNA. PARP is a crucial enzyme in the immune response and has been implicated in a number of diseases, including cancer.

The discovery of PPP4R1L as a drug target

The search for new treatments and drug targets is a constant in the pharmaceutical industry. One of the promising targets in this field is PPP4R1L, a protein that has been shown to play a crucial role in the regulation of cellular processes. Researchers have discovered that PPP4R1L is a good candidate for a drug target due to its unique structure and its involvement in the production of ROS.

The role of PPP4R1L in the production of ROS

ROS are reactive oxygen species that can cause damage to cellular DNA. These ROS can be produced by a variety of cellular processes, including cell division, stress, and inflammation. One of the ways that ROS are produced is through the PARP enzyme, which is a crucial regulator of the production of ROS.

PPP4R1L is a key regulator of the PARP enzyme

The PARP enzyme is a crucial regulator of the production of ROS. It is involved in the production of reactive oxygen species (ROS) by catalyzing the reaction between ADP and phosphate. The production of ROS by PARP is critical for the immune response and for the regulation of cellular processes.

PPP4R1L is a key regulator of the PARP enzyme

Research has shown that PPP4R1L plays a crucial role in the regulation of the PARP enzyme. Studies have shown that PPP4R1L is a direct substrate of the PARP enzyme and that its activity is regulated by the enzyme. Additionally, research has shown that PPP4R1L interacts with the PARP enzyme and that this interaction may play a role in the regulation of the PARP enzyme.

The potential implications of PPP4R1L as a drug target

The discovery of PPP4R1L as a drug target is a promising development in the pharmaceutical industry. Studies have shown that PPP4R1L is involved in the production of ROS, which can cause damage to cellular DNA. Additionally, PPP4R1L has been shown to play a crucial role in the regulation of the PARP enzyme, which is involved in the production of ROS.

The potential implications of PPP4R1L as a drug target are significant. If PPP4R1L is successfully targeted, it could lead to the development of new treatments for a variety of diseases, including cancer. Additionally, the discovery of PPP4R1L as a drug target could also lead to the development of new inhibitors for the PARP enzyme, which could be used to treat a variety of diseases.

Conclusion

In conclusion, PPP4R1L is a protein that has been shown to play a crucial role in the regulation of cellular processes. Its unique structure and its involvement in the production of ROS make it an attractive candidate for a drug target. The potential implications of PPP4R1L as a drug target are significant, and further research is needed to fully understand its role in cellular processes and its potential as a treatment.

Protein Name: Protein Phosphatase 4 Regulatory Subunit 1 Like (pseudogene)

Functions: May be a regulatory subunit of serine/threonine-protein phosphatase 4

The "PPP4R1L Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PPP4R1L comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets